Aldeyra Therapeutics (ALDX) Current Leases (2019 - 2026)
Aldeyra Therapeutics (ALDX) posted Current Leases of $212769.0 for Q1 2026, down 24.16% on a QoQ basis from $280537.0 in Q4 2025, and down 16.67% year-over-year from $255342.0 in Q1 2025.
Aldeyra Therapeutics (ALDX) Current Leases (2019 - 2026) Analysis & Trends
Aldeyra Therapeutics' Current Leases history runs 8 years deep, the most recent figure standing at $212769.0 for Q1 2026.
- Quarterly Current Leases fell 16.67% year-over-year to $212769.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $212769.0 (down 16.67% YoY) and the FY2025 annual result came in at $280537.0, up 3.28% from the prior year.
- Current Leases was $212769.0 for Q1 2026 at Aldeyra Therapeutics, down from $280537.0 in the prior quarter.
- Across five years, Current Leases topped out at $280537.0 in Q4 2025 and bottomed at $65628.0 in Q3 2023.
- A 5-year average of $226966.2 and a median of $247021.0 in 2024 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2023 — Current Leases slumped 64.45% — and 2024, when it soared 301.11%.
- Aldeyra Therapeutics' Current Leases stood at $249265.0 in 2022, then decreased by 4.04% to $239183.0 in 2023, then climbed by 13.57% to $271631.0 in 2024, then gained by 3.28% to $280537.0 in 2025, then declined by 24.16% to $212769.0 in 2026.
- Business Quant data shows ALDX's Current Leases at $212769.0 in Q1 2026, $280537.0 in Q4 2025, and $271948.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.14 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.46 Bn | 37.46 Bn | - | 16.61 Mn |
| 10 | Aldeyra Therapeutics | 94.10 Mn | 94.10 Mn | - | 212,769.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 212,769.00 |
| Dec 31, 2025 | 280,537.00 |
| Sep 30, 2025 | 271,948.00 |
| Jun 30, 2025 | 263,551.00 |
| Mar 31, 2025 | 255,342.00 |
| Dec 31, 2024 | 271,631.00 |
| Sep 30, 2024 | 263,241.00 |
| Jun 30, 2024 | 255,039.00 |
| Mar 31, 2024 | 247,021.00 |
| Dec 31, 2023 | 239,183.00 |
| Sep 30, 2023 | 65,628.00 |
| Jun 30, 2023 | 129,785.00 |
| Mar 31, 2023 | 190,202.00 |
| Dec 31, 2022 | 249,265.00 |
| Sep 30, 2022 | 184,599.00 |
| Jun 30, 2022 | 242,636.00 |
| Mar 31, 2022 | 236,048.00 |
| Dec 31, 2021 | 229,607.00 |
| Sep 30, 2021 | 222,158.00 |
| Jun 30, 2021 | 118,401.00 |